Latest Posts


Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More


Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

BioNJ’s 14th Annual BioPartnering Conference

Join Dr. Gunjan Bhardwaj, Founder & CEO, Dr. Frank Grams, CCO, and Sven Krause, President – North America for Partex at BioNJ’s BioPartnering Conference.

BioNJ’s 14th Annual BioPartnering Conference, the premier partnering event for entrepreneurs looking to connect with investors and biopharmaceutical companies for funding and collaboration opportunities is taking place on the 14th of May in Jersey City, NJ, USA.

Explore Collaboration: Learn how Partex’s innovative approach can accelerate your drug development journey!

Dr. Gunjan Bhardwaj

Founder & CEO Partex

Dr. Frank Grams

CCO, Partex

Sven Krause
President, Partex, North America

May 14, 2024

Jersey City, NJ USA

To find out more details visit: